日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: TP53 drives invasion through expression of its Δ133p53β variant

更正:TP53 通过表达其 Δ133p53β 变体驱动侵袭

Gadea, Gilles; Arsic, Nikola; Fernandes, Kenneth; Diot, Alexandra; Joruiz, Sebastien; Abdallah, Samer; Meuray, Valerie; Vinot, Stéphanie; Anguille, Christelle; Remenyi, Judit; Khoury, Marie P; Quinlan, Philip R; Purdie, Colin A; Jordan, Lee B; Fuller-Pace, Frances V; de Toledo, Marion; Cren, Maïlys; Thompson, Alastair M; Bourdon, Jean-Christophe; Roux, Pierre

TP53 drives invasion through expression of its Δ133p53β variant

TP53 通过表达其 Δ133p53β 变体驱动侵袭

Gadea, Gilles; Arsic, Nikola; Fernandes, Kenneth; Diot, Alexandra; Joruiz, Sébastien M; Abdallah, Samer; Meuray, Valerie; Vinot, Stéphanie; Anguille, Christelle; Remenyi, Judit; Khoury, Marie P; Quinlan, Philip R; Purdie, Colin A; Jordan, Lee B; Fuller-Pace, Frances V; de Toledo, Marion; Cren, Maïlys; Thompson, Alastair M; Bourdon, Jean-Christophe; Roux, Pierre

The p53 isoform Δ133p53β promotes cancer stem cell potential

p53亚型Δ133p53β促进癌症干细胞潜能

Arsic, Nikola; Gadea, Gilles; Lagerqvist, E Louise; Busson, Muriel; Cahuzac, Nathalie; Brock, Carsten; Hollande, Frederic; Gire, Veronique; Pannequin, Julie; Roux, Pierre

Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

细胞周期蛋白 A2 诱变分析:对 CDK 激活和细胞定位要求的新见解

Bendris Nawal, Lemmers Bénédicte, Blanchard Jean-Marie, Arsic Nikola

Identification of a new hybrid serum response factor and myocyte enhancer factor 2-binding element in MyoD enhancer required for MyoD expression during myogenesis

在肌生成过程中,MyoD 增强子中鉴定出一种新的混合血清反应因子和肌细胞增强因子 2 结合元件,该元件是 MyoD 表达所必需的。

L'honore, Aurore; Rana, Vanessa; Arsic, Nikola; Franckhauser, Celine; Lamb, Ned J; Fernandez, Anne